Persones / Equip Humà

Jordi Antón López

Buscador de publicacions

Publicacions

  • Vastert, SJ, Boom, V, Anton-Lopez J, Constantin, T, Dolezalova, P, Horneff, G, Lahdenne, P, Magnusson, B, Minden, K, Nistala, K, Quartier, P, Rumba-Rozenfelde, I, Ruperto, N, Piccolo, VR, Russo, RAG, Uziel, Y, Wouters, C, Martini, A, Ravelli, A, Foster, H and Wulffraat, N.

    Single Hub and Access Point for Paediatric Rheumatology in Europe (SHARE)- Evidence Based Recommendations for Diagnosis and Treatment of Juvenile Idiopathic Arthritis.

    ARTHRITIS & RHEUMATOLOGY . 66: 120-121. Nº de cites: 1

  • Bou-Torrent R, Iglesias-Jimenez E and Anton-Lopez J.

    Treatment of Uveitis Associated with Juvenile Idiopathic Arthritis

    CURRENT RHEUMATOLOGY REPORTS . 16(8): 437-437. Nº de cites: 12

    [doi:10.1007/s11926-014-0437-4]

  • Baroja-Mazo A, Martín-Sánchez F, Gomez AI, Martínez CM, Amores-Iniesta J, Compan V, Barberà-Cremades M, Yagüe J, Ruiz-Ortiz E, Anton-Lopez J, Buján S, Couillin I, Brough D, Arostegui JI and Pelegrín P.

    The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response

    NATURE IMMUNOLOGY . 15(8): 738-748. Nº de cites: 621

    [doi:10.1038/ni.2919]

  • Iglesias-Jimenez E, Torrente V, Bou-Torrent R, Ricart S, Maria Isabel Gonzalez Fernandez, Sánchez-Manubens J, Calzada-Hernández J and Anton-Lopez J.

    Non-systemic juvenile idiopathic arthritis outcome after reaching clinical remission with anti-TNF-alpha therapy: a clinical practice observational study of patients who discontinued treatment

    RHEUMATOLOGY INTERNATIONAL . 34(8): 1053-1057. Nº de cites: 22

    [doi:10.1007/s00296-013-2884-z]

  • Hofer M, Pillet P, Cochard MM, Berg S, Krol P, Kone-Paut I, Rigante D, Hentgen V, Anton-Lopez J, Brik R, Neven B, Touitou I, Kaiser D, Duquesne A, Wouters C and Gattorno M.

    International periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome cohort: description of distinct phenotypes in 301 patients

    RHEUMATOLOGY . 53(6): 1125-1129. Nº de cites: 123

    [doi:10.1093/rheumatology/ket460]

  • Pérez Martínez E, Camprubí-Camprubí M, Ramos Cebrián M, Anton-Lopez J, Apodaca Saracho A, Lopez Ramos MG and García-Alix A.

    Treatment with bisphosphonates in severe hypercalcemia due to subcutaneous fat necrosis in an infant with hypoxic-ischemic encephalopathy

    JOURNAL OF PERINATOLOGY . 34(6): 492-493. Nº de cites: 9

    [doi:10.1038/jp.2014.28]

  • Pelegrín L, Casaroli-Marano R, Anton-Lopez J, García de Vicuña-Muñoz C, Molina-Prat N, Ignacio Aróstegui J, Yagüe J, Ríos J and Adán A.

    Predictive Value of Selected Biomarkers, Polymorphisms, and Clinical Features for Oligoarticular Juvenile Idiopathic Arthritis-associated Uveitis

    OCULAR IMMUNOLOGY AND INFLAMMATION . 22(3): 208-212. Nº de cites: 17

    [doi:10.3109/09273948.2013.841495]

  • Sánchez-Manubens J, Bou-Torrent R and Anton-Lopez J.

    Diagnosis and classification of Kawasaki disease

    JOURNAL OF AUTOIMMUNITY . 48-49: 113-117. Nº de cites: 48

    [doi:10.1016/j.jaut.2014.01.010]

  • Torrente V, Bou-Torrent R, Ricart S, Santin-Riba P, Rodríguez N, Ros J and Anton-Lopez J.

    Leflunomide Use in Juvenile Idiopathic Arthritis Following Methotrexate Discontinuation: A One-Year Clinical Practice Retrospective Review

    Annals of Paediatric Rheumatology . 3(1): 26-28.

  • Bishop N, Adami S, Ahmed SF, Anton-Lopez J, Arundel P, Burren CP, Devogelaer JP, Hangartner T, Hosszú E, Lane JM, Lorenc R, Mäkitie O, Munns CF, Paredes A, Pavlov H, Plotkin H, Raggio CL, Reyes ML, Schoenau E, Semler O, Sillence DO and Steiner RD.

    Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial

    Lancet . 382(9902): 1424-1432. Nº de cites: 139

    [doi:10.1016/S0140-6736(13)61091-0]